FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins

FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy. Despite this change, discontinue statins in most pregnant patients or consider the ongoing therapeutic needs of the individual patient.

Source: FDA Center for Drug Evaluation and Research - What's New - July 20, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news